Publications by authors named "Bruno Paiva"

100Publications

Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment.

Haematologica 2020 Jun 5;105(9):e470-473. Epub 2020 Jun 5.

Clinica Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain; Centro de Investigacion Medica Aplicada (CIMA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.235135DOI Listing
June 2020

Measurable residual disease in multiple myeloma: ready for clinical practice?

J Hematol Oncol 2020 06 22;13(1):82. Epub 2020 Jun 22.

Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-020-00911-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310444PMC
June 2020

EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets.

J Immunol Methods 2019 12 24;475:112662. Epub 2019 Aug 24.

Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain and; Centro de Investigación Biomédica en Red de Cáncer: CIBER-ONC (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2019.112662DOI Listing
December 2019

Analysis of monocitary subpopulations in relation to cardiovascular risk factors.

Clin Investig Arterioscler 2019 Jul - Aug;31(4):152-159. Epub 2019 Apr 6.

Departamento de Hematología, Clínica Universidad de Navarra, Pamplona, España; Laboratorio de Aterotrombosis, CIMA-Universidad de Navarra, Pamplona, España; CIBERCV, Madrid, España. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02149168193003
Publisher Site
http://dx.doi.org/10.1016/j.arteri.2019.02.003DOI Listing
January 2020

Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma.

Blood 2019 05 28;133(18):1953-1963. Epub 2019 Feb 28.

Clinica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-09-874396DOI Listing
May 2019

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.

Clin Cancer Res 2019 May 28;25(10):3176-3187. Epub 2019 Jan 28.

Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1597DOI Listing
May 2019

How deep is the myeloma iceberg?

Blood 2018 12;132(23):2424-2425

Clinica Universidad de Navarra.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-10-878637DOI Listing
December 2018

Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma.

Front Immunol 2018 16;9:2431. Epub 2018 Nov 16.

Department of Haematooncology, University Hospital Ostrava, Ostrava, Czechia.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2018.02431
Publisher Site
http://dx.doi.org/10.3389/fimmu.2018.02431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250817PMC
October 2019

Flow Cytometry.

Hematol Oncol Clin North Am 2018 10 31;32(5):765-775. Epub 2018 Jul 31.

Department of immunology, Clínica Universidad de Navarra, Av. Pio XII, 36, Pamplona, 31008, Spain; Centre for Applied Medical Research (CIMA), Pamplona, Spain; Healthcare Research Institute of Navarre (IDISNA), Pamplona, Spain; CIBERONC, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2018.05.004DOI Listing
October 2018

How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers.

J Immunol Methods 2019 12 20;475:112388. Epub 2017 Nov 20.

CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2017.11.007DOI Listing
December 2019

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials.

J Clin Oncol 2017 Sep 12;35(25):2900-2910. Epub 2017 May 12.

Juan-Jose Lahuerta, Maria-Teresa Cedena, Joaquin Martinez-Lopez, and María-Luisa Martín-Ramos, Hospital 12 de Octubre, CIBERONC; Raquel de Paz, Hospital Universitario La Paz; Rafael Martinez, Hospital Clínico San Carlos; Adrian Alegre, Hospital Universitario La Princesa, Madrid; Bruno Paiva and Jesus F. San-Miguel, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona; Laura Rosiñol, and Joan Blade, Hospital Clínic de Barcelona, Barcelona; Maria-Belen Vidriales, Noemi Puig, Norma C. Gutierrez, Alejandro Martin, and María-Victoria Mateos, Hospital Universitario de Salamanca Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBERONC; Alberto Orfao, Servicio General de Citometría-NUCLEOS, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), IBSAL and Department of Medicine, Universidad de Salamanca, CIBERONC, Salamanca; Lourdes Cordón and Javier De la Rubia, Hospital Universitario y Politécnico La Fe; Ana-Isabel Teruel, Hospital Clínico de Valencia, Valencia; Albert Oriol, Hospital Germans Trias i Pujol, Badalona; María-Asunción Echeveste, Hospital de Donostia, San Sebastian; Felipe de Arriba, Hospital Morales Meseguer, Murcia; Miguel T. Hernandez, Hospital Universitario de Canarias, Tenerife; Luis Palomera, Hospital Universitario Lozano Blesa, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.2517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568033PMC
September 2017

Is immunotherapy here to stay in multiple myeloma?

Haematologica 2017 03 12;102(3):423-432. Epub 2017 Jan 12.

Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.152504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394971PMC
March 2017

Origin of Waldenstrom's macroglobulinaemia.

Best Pract Res Clin Haematol 2016 06 6;29(2):136-147. Epub 2016 Oct 6.

Servicio General de Citometría de la Universidad de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.08.024DOI Listing
June 2016

Modulation of Synovial Fluid-Derived Mesenchymal Stem Cells by Intra-Articular and Intraosseous Platelet Rich Plasma Administration.

Stem Cells Int 2016 12;2016:1247950. Epub 2016 Oct 12.

Arthroscopic Surgery Unit Research, Hospital Vithas San Jose, C/Beato Tomás de Zumarraga 10, 01008 Vitoria-Gasteiz, Spain; Arthroscopic Surgery Unit, Hospital Vithas San Jose, C/Beato Tomás de Zumarraga 10, 01008 Vitoria-Gasteiz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/1247950DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080490PMC
October 2016

Utility of flow cytometry studies in the management of patients with multiple myeloma.

Curr Opin Oncol 2016 11;28(6):511-517

Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000331DOI Listing
November 2016

Multiple Myeloma Minimal Residual Disease.

Cancer Treat Res 2016;169:103-122

Centro de Investigacion Medica Aplicada (CIMA), Clinica Universidad de Navarra, IDISNA, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-40320-5_7DOI Listing
June 2017

Engineering Anti-myeloma Responses Using Affinity-Enhanced TCR-Engineered T Cells.

Cancer Cell 2015 Sep;28(3):281-3

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, 31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2015.08.009DOI Listing
September 2015

Gelatin and galactomannan-based scaffolds: Characterization and potential for tissue engineering applications.

Carbohydr Polym 2015 Nov 20;133:8-18. Epub 2015 Jun 20.

Post-Graduate Program of Materials Science, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Bento Gonçalves, 9500, Sala A216, CEP: 91540-000, Porto Alegre, RS, Brazil; Institute of Chemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Bento Gonçalves, 9500, IQ, CEP: 91501-970, Porto Alegre, RS, Brazil. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carbpol.2015.06.039DOI Listing
November 2015

Assessment of minimal residual disease in myeloma and the need for a consensus approach.

Cytometry B Clin Cytom 2016 Jan 23;90(1):21-5. Epub 2015 Sep 23.

Laboratory of Pathology, NCI, Bethesda, Maryland, 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511969PMC
January 2016

Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases.

Cytometry B Clin Cytom 2016 Jan 31;90(1):91-100. Epub 2015 Jul 31.

Centro de Investigación del Cáncer (Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL), Instituto Biosanitario de Salamanca (IBSAL), Servicio General de Citometría y Departamento De Medicina (NUCLEUS), Universidad de Salamanca (Salamanca), Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21269DOI Listing
January 2016

Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.

Cytometry B Clin Cytom 2016 Jan 31;90(1):61-72. Epub 2015 Jul 31.

Centro de Investigación del Cáncer (Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL), Instituto Biosanitario de Salamanca (IBSAL), Servicio de Citometría y Departamento de Medicina-NUCLEUS, Universidad de Salamanca (Salamanca), Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cyto.b.21265
Publisher Site
http://dx.doi.org/10.1002/cyto.b.21265DOI Listing
January 2016

Treatment for patients with newly diagnosed multiple myeloma in 2015.

Blood Rev 2015 Nov 12;29(6):387-403. Epub 2015 Jun 12.

Clínica Universidad de Navarra/Centro de Investigación Médica Aplicada (CIMA), Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2015.06.001DOI Listing
November 2015

A rare case of endometrioma in a bitch.

Acta Vet Scand 2015 Jun 18;57:31. Epub 2015 Jun 18.

Laboratório de Patologia do Departamento de Clínica e Cirurgia Veterinárias, Escola de Veterinária da Universidade Federal de Minas Gerais, Avenida Presidente Antônio Carlos, 6627, CEP: 30.161-970, Belo Horizonte, Minas Gerais, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13028-015-0123-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475315PMC
June 2015

Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.

Cytometry B Clin Cytom 2016 Jan 6;90(1):26-30. Epub 2015 Jul 6.

HMDS, Department of Haematology, St, James's Institute of Oncology, Leeds, Ls9, 7TF, United Kingdom.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cyto.b.21249
Publisher Site
http://dx.doi.org/10.1002/cyto.b.21249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511978PMC
January 2016

New criteria for response assessment: role of minimal residual disease in multiple myeloma.

Blood 2015 May 2;125(20):3059-68. Epub 2015 Apr 2.

Cancer Research Center Instituto de Biologia Celular y Molecular del Cancer-Consejo Superior de Investigaciones Científicas/University of Salamanca, Department of Medicine Cytometry Service, and Instituto Biosanitario de Salamanca, University of Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-11-568907DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513329PMC
May 2015

Is this the time to introduce minimal residual disease in multiple myeloma clinical practice?

Clin Cancer Res 2015 May 9;21(9):2001-8. Epub 2015 Mar 9.

Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2841DOI Listing
May 2015

Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting.

Cytometry B Clin Cytom 2016 Jan 2;90(1):31-9. Epub 2015 Jun 2.

Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21228DOI Listing
January 2016

Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 inhibition as an antimyeloma strategy.

Mol Cancer Ther 2014 Feb 15;13(2):504-16. Epub 2014 Jan 15.

Corresponding Author: Atanasio Pandiella, Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, 37007 Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0022DOI Listing
February 2014

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.

N Engl J Med 2013 Aug;369(5):438-47

Hospital Universitario de Salamanca, Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca-Consejo Superior de Investigaciones Científicas, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1300439DOI Listing
August 2013

New tools for diagnosis and monitoring of multiple myeloma.

Am Soc Clin Oncol Educ Book 2013

From the Hospital Universitario de Salamanca, Salamanca, Spain; IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EdBook_AM.2013.33.e313DOI Listing
November 2015

Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.

Haematologica 2013 Feb 28;98(2):279-87. Epub 2012 Aug 28.

Department of Medicine and Service of Cytometry, IBSAL and Centro de Investigación del Cáncer (IBMCC USAL-CSIC), University Hospital of Salamanca and University of Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2011.060632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561437PMC
February 2013